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Abstract
Alcohol consumption during adolescence has long-term sexually dimorphic effects on anxiety behavior and mood
disorders. We have previously shown that repeated binge-pattern alcohol exposure increased the expression of two critical
central regulators of stress and anxiety, corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP), in
adolescent male rats. By contrast, there was no effect of alcohol on these same genes in adolescent females. Therefore, we
tested the hypothesis that 17b-estradiol (E2), the predominant sex steroid hormone in females, prevents alcohol-induced
changes in CRH and AVP gene expression in the paraventricular nucleus (PVN) of the hypothalamus. To test this hypothesis,
postnatal day (PND) 26 females were ovariectomized and given E2 replacement or cholesterol as a control. Next, they were
given an alcohol exposure paradigm of 1) saline alone, 2) acute (single dose) or 3) a repeated binge-pattern. Our results
showed that acute and repeated binge-pattern alcohol treatment increased plasma ACTH and CORT levels in both E2- and
Ch-treated groups, however habituation to repeated binge-pattern alcohol exposure was evident only in E2-treated animals.
Further, repeated binge-pattern alcohol exposure significantly decreased CRH and AVP mRNA in Ch-, but not E2-treated
animals, which was consistent with our previous observations in gonad intact females. We further tested the effects of E2
and alcohol treatment on the activity of the wild type CRH promoter in a PVN-derived neuronal cell line. Alcohol increased
CRH promoter activity in these cells and concomitant treatment with E2 completely abolished the effect. Together our data
suggest that E2 regulates the reactivity of the HPA axis to a repeated stressor through modulation of the habituation
response and further serves to maintain normal steady state mRNA levels of CRH and AVP in the PVN in response to a
repeated alcohol stressor.
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Introduction
Sexually dimorphic patterns of addictive behavior emerge
during adolescence and often persist in adulthood. For example,
in early adolescence (ages 12–17), the amount and frequency of
alcohol consumption does not differ between boys and girls, yet it
becomes markedly skewed in young adults with males consuming
significantly more alcohol than females [1]. Consumption of
alcohol for individuals between the ages of 18 and 25 tends to be
excessive and sporadic (‘‘binge’’ drinking) which leads to
increased risk-taking behavior [1,2,3,4,5]. One possible explana-
tion for these sex differences is that early experimentation with
alcohol (i.e. 12–16 years old) differentially activates the stress
response, and/or centrally-mediated reward systems, resulting in
divergent behavioral patterns that emerge in late adolescents/
young adults.
Correlative studies have demonstrated that over 50% of patients
with alcohol dependency also have anxiety-related or depression-
related psychiatric disorders [6], and these types of disorders are
often associated with an abnormal stress response. Under normal
physiological conditions, an acute psychological or physical
stressor activates the hypothalamo-pituitary adrenal (HPA) axis.
Hypothalamic corticotrophin-releasing hormone (CRH) stimulates
adrenocorticotropic hormone (ACTH) release from the anterior
pituitary which in turn, causes the release of adrenal glucocorti-
coids. This sequence of events sets up a negative feedback system
whereby increased circulating glucocorticoid levels serve to inhibit
the additional release of hypothalamic CRH. Interestingly,
alcoholic women have a higher incidence of clinically diagnosed
anxiety disorders compared to alcoholic men [7,8], possibly due to
the inherent sex differences in the stress responses of the HPA axis
[9,10].
Previously, we showed that adolescent repeated binge-pattern
alcohol exposure altered the central expression of CRH and AVP
mRNA in the paraventricular nucleus (PVN), the major brain
region involved in modulating the physiological stress response
[11]. Importantly, the effects of alcohol on these central gene
expression profiles in the PVN occurred only in males, yet the
peripheral alcohol-induced CORT response was similar in both
sexes [11]. Overall, these data demonstrated that repeated binge-
pattern alcohol exposure during puberty fundamentally dysregu-
lated the HPA axis in a sex-specific manner, yet the molecular
mechanisms mediating this sexual dimorphism remain unknown.
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gonadal steroid hormone levels and increased gonadal growth,
therefore it is reasonable to predict that the sexual dimorphism
previously observed is regulated, in part, by differences in
circulating gonadal steroid hormones. The main circulating
gonadal steroid hormone in reproductively competent females is
17b-estradiol (E2). Therefore, we hypothesized that the failure of
binge-pattern alcohol exposure to increase CRH and AVP gene
expression in the PVN of female rats is due to the presence of
circulating E2. We also tested the effects of concomitant alcohol
and E2 on CRH promoter activity in a PVN-derived cell line.
Overall, our results indicated that E2 was required for very specific
aspects of the alcohol-mediated changes in the female HPA axis,
but that other, as yet undetermined, factors are also important for
mediating the overall sexually dimorphic response of the HPA axis
to alcohol.
Materials and Methods
Ethics Statement
All animal procedures were approved by the Loyola University
Stritch School of Medicine Institutional Animal Care and Use
Committee (IACUC) permit #2007027.
Animals
Female Wistar rats were purchased from Charles River
Laboratories (Wilmington, MA) at weaning (postnatal day (PND)
23) and allowed to acclimate for 3 days after arrival. On PND 26,
they were bilaterally ovariectomized (OVX) and implanted with a
0.5 cm silastic capsule containing either crystalline 17b-estradiol
(E2) or cholesterol (Ch). This dose has been shown in previous
studies to yield plasma E2 levels of approximately 64 pg/ml
[12,13], which is consistent with levels observed during diestrous
[14] and was chosed to mimic low circulating hormone levels
present in peripubertal females. Animals were allowed to recover
from surgery until PND 30 at which time they were handled for
5 min/once/day for 7 days to acclimate the animals to non-
specific handling stress. EtOH treatment (see details below) began
on PND 37 which has been defined in the literature as peri-
puberty in rats [15,16,17]. Animals were housed in pairs on a
12:12 light/dark cycle with lights on at 07.00 h and food and
water were available ad libitum for the duration of the treatment
paradigm. All procedures were approved by the Loyola University
Stritch School of Medicine Institutional Animal Care and Use
Committee.
Repeated Binge-Pattern Alcohol Exposure Paradigm and
Treatment Design
E2-treated and Ch-treated animals were randomly assigned to
one of three groups: 1) saline treated (N=8/group), 2) acute
EtOH treated (N=8/group), or 3) repeated binge-pattern EtOH
treated (N=8/group, 3 g/kg/day). The animals in the repeated
binge-pattern EtOH group received one intraperitoneal (IP) 3 g/kg
(20% v/v in saline) EtOH injection every morning at 10:00 AM
for 3 consecutive days, followed by 2 days of saline injections, and
then injected for additional 3 days with EtOH. This repeated
binge-pattern EtOH exposure paradigm has been used previously
to mimic the pattern of binge alcohol consumption in adolescents
[11,18,19] and it has been shown that in pubertal animals this IP
route of alcohol administration does not yield significantly
different blood alcohol concentrations (BAC) or CORT levels
compared to oral gavage [20] (Pak, unpublished data). The
animals were given alcohol in the morning (10:00 AM, CST) and
previous studies showed that morning alcohol administration does
not interfere with normal feeding behavior and does not result in
body weight differences between alcohol-treated and control
animals [11,18]. The acute EtOH-treated group was given 7 days
of saline IP injections (0.9% once/day) followed by one 3 g/kg of
EtOH IP injection on the last day of treatment (day 8). The saline
group was treated with saline alone (once/day) for 8 consecutive
days. On the last day of treatment (PND 44), animals were killed
by rapid decapitation 1.0 h following the final injection.
Blood alcohol concentration (BAC) assay
Blood alcohol levels were determined by measuring the change
in absorbance at 340 nm following enzymatic oxidation of EtOH
to acetylaldehyde (Point Scientific Alcohol Reagent Kit). Assay
range is 0 to 400 mg/dl and intra and interassay CV=7.86 and
8.9%, respectively.
Plasma hormone measurements
Plasma ACTH and CORT were measured using radioimmu-
noassay (RIA) as previously reported [11,19]. Briefly,
125I-ACTH
(DIASORIN, Stillwater, MN), rabbit IgG-ACTH-I primary
antibody (Ig Corp, Nashville, TN) and goat anti-rabbit G-globulin
secondary antibody (CalBiochem, San Diego, CA) was used for
measurements of ACTH.
3H-CORT (PerkinElmer, Waltham,
MA), rabbit CORT antiserum (MP Biomedicals, Solon, OH), and
CORT-standards (4-PREGNEN, 11b, 21-DIOL-3,20-DIONE-
Steraloids, Inc) were used to measure CORT. Intraassay CVs
were 4.94 and 4.96%, and interassay CVs were 14.9 and 9.7%,
respectively.
Circulating E2 levels were measured by E2 Extraction-
Chromatography-RIA (Endocrine Technology and Support
Laboratory, Oregon National Primate Center, Oregon Health
Science University, Portland, OR). The reported intraassay and
interassay CV were 12% and 18%, respectively.
Tissue collection and qRT-PCR
Animals were killed by rapid decapitation 60 min following the
last injection. Trunk blood and brains were collected and brains
were rapidly frozen in isopentane (230uC) and stored at 280uC.
Brain samples and qRT-PCR were performed as previously
reported. Briefly, brains were sectioned at 200 mm on a freezing
microtome and the paraventricular (PVN) and supraoptic (SON)
nuclei were microdissected using a 0.75 mm Palkovit’s brainpunch
tool (Stoelting Co., Wood Dale, IL). The specificity of the
microdissected regions was confirmed using The Rat Brain in
Stereotaxic Coordinates, Fourth Edition Atlas (G. Paxinos and C.
Watson). For the PVN, a 0.75 mm area was microdissected on
each side of the third ventricle between 0.8 mm and 2.12 mm
posterior to Bregma, 8 mm below the top of the brain [21]. For
the SON a 0.4 mm area was microdissected 9.5 mm below the top
of the brain between 0.8 mm and 3.14 mm posterior to Bregma.
Total RNA was isolated using Trizol reagent (Invitrogen Inc.,
Carlsbad, CA) according to the manufacturer’s directions.
Following RNA isolation, 0.5 mg total RNA was reverse
transcribed using the First Strand Synthesis SuperMix for qRT-
PCR (Invitrogen Inc., Carlsbad, CA). Roche FastStart SYBR
Green Master Mix was added to intron-spanning AVP specific
upper and lower primers: 5-GGGCAGGTAGTTCTCCTCCT;
5-CACCTCTGCCTGCTACTTCC) and intron-spanning CRH
primers: 5-GAGAAAGGGGAAAGGCAAAG; 5-ATCA-
GAATCGGCTGAGGTTG). Quantification of the target gene
expression was achieved by extrapolating from standard curve of
known concentrations of AVP or CRH ran simultaneously in the
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guanine phosphoribosyl transferase 1 (HPRT) housekeeping gene,
as it is not altered by EtOH treatment [11].
Cell Culture
The rat PVN-derived cell line (IVB cell line, generously
provided by Dr. John Kaskow, University of Cincinnati) was used
for all transient transfections. Cells were maintained in DMEM
containing 4.5% glucose and L-glutamine (HyClone Laboratories,
Logan, UT) supplemented with 10% fetal bovine serum (FBS).
Cells were grown to 90% confluency and all transient transfections
were performed within the same 10 passages.
Reporter gene constructs and expression vectors
The full-length CRH promoter was generously provided and
validated by Dr. Audrey F. Seasholtz (University of Michigan, Ann
Arbor, MI) and then modified as follows: the full-length promoter
fragment (22125/+94) was excised from the pUC18 vector by
restriction enzyme digestion for EcoR1 (59) and HINDIII (39) and
subsequently subcloned into the promoterless luciferase vector
(pGL3 basic, Promega Corp., Madison, WI). The pRL-tk
luciferase reporter vector (Promega Corp., Madison, WI) was
used as an internal control for calculating plasmid transfection
efficiency.
Transient Transfections and Dual Luciferase Assay
Cells were plated at a density of 20,000 cells/well in opaque 96-
well plates for 24.0 h prior to transfection to achieve a final
confluency of 80–90%. All constructs were transfected in replicates
of six wells within each assay, and each transfection assay was
repeated in a minimum of 6 independent experiments. Transfec-
tions were performed using a lipid-mediated transfection reagent
(Fugene6, Roche Molecular Biomedical, Indianapolis, IN) accord-
ing to the manufacturer’s instructions. 8 h after transfection cells
were incubated in vehicle, 10 nM E2 or an estrogen receptor-beta
(ERb)-specific agonist, 100 nM 5alpha-androstane-3beta,17beta-
diol (3bdiol). Cells were incubated with hormones overnight
(15.0 h) and then treated with 100 mM EtOH for 2.0 h. The Dual
Luciferase Reporter (DLR) kit (Promega Inc., Madison, WI) was
used according to manufacturer’s directions. Briefly, cells were
lysed in 20 ml of lysis buffer, incubated on a shaker for 20 min at
room temperature and then loaded into a multiple well plate
reader (Synergy HT, Biotech). The plate reader is equipped with
dual injectors and automatically dispensed 100 ml firefly luciferase
substrate (LARII) followed by ‘‘stop-and glo’’ substrate for renilla
luciferase. Results were analyzed using Gen5 software system
(Biotech Inc., Winooski, VT).
Statistical Analysis
Statistical analyses were performed by the Biostatistics Core
Facility at Loyola University Stritch School of Medicine in
consultation with Dr. James Sinacore. A 262 two-way analysis of
variance (ANOVA) was used to test for interactions between
hormone and alcohol treatments and for main effects of these
treatments with respect to the following dependent variables:
plasma BAC, plasma CORT levels, CRH mRNA in the PVN,
and AVP mRNA in the PVN and SON. Tukeys post hoc test was
used if ANOVA achieved significance. For in vitro studies, 263
two-way ANOVA was used to test for interactions between alcohol
and specific hormone (vehicle, E2,3 bdiol) treatments and for main
effects of vehicle or alcohol treatment with respect to the CRH
promoter activity. Tukeys post hoc test was used if ANOVA
achieved significance. All tests were performed using SigmaStat
Statistical Analysis Software. A p-value of less than 0.05 was
designated as statistically significant.
Results
Effects of Ch-, E2, and EtOH treatment on body weight in
OVX adolescent female rats
Animals were weighed every-other day during the course of the
treatment paradigm in order to determine the effects of hormone
and concomitant EtOH treatment on body weight. A repeated
measures mixed ANOVA revealed that there was a significant
main effect of age (F(1,44)=9.9. p=0.003), but not EtOH
treatment, on body weight (F(2,44)=0.252; p=0.388). The Ch-
treated animals gained weight at a faster pace compared to the
animals treated with E2 (Fig. 1), which is consistent with the
reported anorexigenic effects of E2. Concomitant EtOH treatment
had no additional effects on body weight and all variation was
exclusively due to hormone treatment (Fig. 1).
Circulating E2 levels were 6567.3 pg/ml in E2-treated OVX
females and were below the detectable limits of the assay in OVX
Ch-treated females. Importantly, EtOH treatment did not alter E2
levels, as there were no differences in plasma E2 levels between
EtOH treatment groups. These data, together with body weight
data, indicate that E2 replacement via silastic capsules was effective
in these experiments and raised plasma E2 levels to expected
values.
Blood alcohol concentrations (BAC) in Ch- and E2-treated
OVX adolescent female rats
Blood alcohol concentrations (BAC) were measured on the final
day of treatment (day 8) 60 min following injections. EtOH
treatment resulted in a BAC of 257.09619.97 mg/dl and
275.77622.94 in E2- and Ch-treated females, respectively
(Fig. 2). These values are consistent with the defined BAC
threshold of binge drinking [22]. Two-way ANOVA showed that
there was a main effect of EtOH treatment (F(2,38)=60.368,
p,0.001) on BAC, but no main effect of hormone treatment
(F(2,38)=1.595; p=0.516). BAC were similar in all groups
regardless of hormone treatment.
Effects of repeated binge-pattern EtOH exposure on
plasma ACTH and CORT levels in Ch- or E2 – treated OVX
adolescent female rats
Circulating ACTH and CORT are important peripheral
indicators of a physiological stress response. Therefore, plasma
ACTH and CORT levels were measured by RIA in Ch- and E2-
treated animals in order to determine if E2 modulates the
physiological stress response to EtOH. Overall, a two-way
ANOVA revealed that there was a main effect of hormone
treatment (F(1,35)=10.563; p=0.003), a main effect of EtOH
treatment (F(2,35)=24.219; p,0.001), and a significant interac-
tion on plasma ACTH levels (Fig. 3A). Analysis of plasma CORT
levels revealed that there was no main effect of hormone treatment
(F(2,36)=0.318; p=0.73) and that there was a main effect of
EtOH treatment (F(2,36)=27.834; p,0.001) on the plasma
CORT levels (Fig. 3B). There was also a significant interaction
between the two factors (p,0.05).
Plasma CORT levels reflected a similar pattern as its upstream
endocrine regulator, ACTH, yet there were striking differences in
the response to EtOH between Ch- and E2-treated animals.
Notably, in OVX animals that received E2 replacement there was
a significant increase in plasma ACTH levels after an acute (one
dose) EtOH exposure (p,0.001), yet a repeated binge-pattern of
E2 Modulates EtOH-Induced HPA Dysregulation
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controls (Fig. 3A, p=0.15). Importantly, this effect was specific to
E2-treatment, as there were no significant differences in plasma
ACTH levels in acute, compared with repeated binge-pattern
EtOH exposure, in the Ch-treated animals (Fig. 3A). In addition,
CORT levels closely mirrored the effects of ACTH, as acute
(p=0.007), but not binge-pattern (p=0.567), EtOH exposure
significantly increased circulating CORT levels only in E2-treated
animals (Fig. 3B). Finally, plasma CORT levels in the saline-
treated group were significantly higher in E2-treated compared
with Ch-treated OVX females (Fig. 3B, p=0.032) as expected
based on previous studies [11,23,24,25].
Effects of repeated binge-pattern EtOH exposure on CRH
and AVP mRNA gene expression in Ch- or E2 – treated
OVX adolescent female rats
CRH and AVP are upstream hypothalamic regulators of
ACTH and CORT. Therefore, CRH and AVP mRNA were
measured using qRT-PCR to determine the specific contribution
of E2 on the female-specific stress responses to EtOH exposure. A
two-way ANOVA revealed that there was a main effect of EtOH
treatment on CRH and AVP mRNA expression and a statistically
significant interaction between hormone and EtOH treatment on
AVP mRNA expression. There were no main effects of hormone
treatment on CRH (F(1,40)=0.0575, p=0.812) or AVP
Figure 1. Effects of EtOH treatment on body weight of ovariectomized females replaced with Ch or E2 during adolescence. Mean
body weights of animals in all treatments groups in females treated with daily IP injections of saline, acute EtOH, or repeated binge-pattern EtOH
paradigm. Data are expressed as mean 6 SEM. (*) indicates a statistically significant difference from control (p,0.05).
doi:10.1371/journal.pone.0032263.g001
Figure 2. Effects of EtOH treatment on blood alcohol levels in ovariectomized female rats. Blood alcohol concentrations (BAC) 1.0 h post-
injection in ovariectomized female rats given subcutaneous implants of Ch or E2 and then treated with saline, acute EtOH or repeated binge-pattern
EtOH. Data are expressed as Data are expressed as mean 6 SEM of EtOH mg/dl. (*) indicates a statistically significant difference from saline-treated
controls (P,0.05).
doi:10.1371/journal.pone.0032263.g002
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Consistent with our previous studies and unlike what we have
observed in male rats [11], neither acute, nor binge-pattern, EtOH
exposure significantly altered CRH and AVP mRNA expression in
the PVN of adolescent female rats given E2 replacement (Fig. 4).
Unexpectedly however in OVX females that were not given E2
replacement, binge-pattern, but not acute EtOH exposure
significantly decreased CRH (p=0.03) (Fig. 4A) and AVP mRNA
expression (p=0.028, Fig. 4B), suggesting that E2 prevented binge-
pattern EtOH-induced changes in CRH and AVP gene
expression.
17b-Estradiol (E2) treatment in vitro abolished EtOH-
induced changes in CRH promoter activity
The data shown in Figure 4 raised the possibility that E2 could
prevent EtOH-induced alterations in CRH mRNA gene expres-
sion. To test possible interactions of EtOH with E2 on the activity
of the CRH promoter, we transfected PVN-derived neuronal cells
with a CRH promoter-luciferase construct and then co-treated
with 100 mM EtOH in the presence or absence of 10 nM E2,o r
100 nM of an ERb specific agonist 3bdiol, and measured
luciferase activity. Statistical analysis revealed that there was a
main effect of alcohol (F(1,45)=4.327, p=0.043) and a main
effect of hormone treatment (F(2,45)=9.119, p,0.001) on CRH
promoter activity. EtOH significantly increased CRH promoter
activity as compared to vehicle-treated controls. (p,0.001) (Fig. 5)
and this effect was abolished in the presence of 10 nM E2
(p=0.947) (Fig. 5). Concomitant treatment with the ERb specific
agonist, 3b-diol, had no effect, suggesting the effects of E2 on CRH
promoter activity are not mediated by ERb.
AVP mRNA expression in the SON after alcohol
treatments in Ch- or E2–treated ovariectomized (OVX)
females
We have previously shown that in adolescent male and female
rats EtOH did not change AVP mRNA expression in the SON, a
main region responsible for osmoregulation, which indicated that
the effects observed in the PVN were not due to the diuretic effects
of EtOH. In this study, AVP mRNA expression in the SON was
also measured in order to verify the HPA axis specificity of EtOH
effects. Consistent with our previous observations in gonad intact
animals, EtOH treatment did not induce any significant
differences in SON AVP mRNA expression (p=0.907) in E2-
treated females, however binge-pattern EtOH treatment signifi-
Figure 3. Effects of EtOH treatment on plasma ACTH and CORT levels in ovariectomized female rats replaced with Ch or E2.
(A) Plasma ACTH and (B) CORT levels in ovariectomized female rats given subcutaneous implants of Ch or E2 and then treated with saline, acute EtOH
or repeated binge-pattern EtOH. Data are expressed as mean 6 SEM of ACTH and CORT ng/ml of blood. Dissimilar symbols indicate a statistically
significant difference between groups (P,0.05).
doi:10.1371/journal.pone.0032263.g003
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compared to saline controls (p,0.001) and acute EtOH treatment
(p=0.003). There were no differences between saline and acute
EtOH groups within Ch-treated females (Fig. 6).
Discussion
The key novel findings in this study demonstrate that the
predominant female sex hormone, E2, was partly responsible for
mediating the sex-specific effects of EtOH on the HPA axis, but it
was not the only contributing factor. Previous work in our
laboratory showed that repeated binge-pattern alcohol exposure in
adolescent rats induced sexually dimorphic changes in the PVN
expression of CRH and AVP, yet there were no sex differences
observed in circulating plasma CORT levels, the downstream
peripheral target of these genes [11]. These data suggested that
EtOH dysregulated the HPA axis of adolescent rats in a sex
specific manner, however the physiological mechanisms underly-
ing these sexually dimorphic effects have not yet been fully
described. Sex steroid hormones, specifically testosterone and/or
E2, are logical contributors to the sex-specific responses in gonad
intact rats. Indeed, the evidence provided in these studies point to
a direct role for E2 in maintaining the reactive tone of the HPA
axis in response to the physiological stressor, EtOH, and two clear
mechanistic actions of E2 emerged: 1) at the level of the
hypothalamus, whereby E2 treatment maintained normal steady
state mRNA levels of CRH and AVP in the PVN in response to an
EtOH stressor, and 2) in the reactivity of the HPA axis to a
repeated stressor through E2-mediated modulation of the
habituation response.
The evidence presented herein supports the hypothesis that, in
females, the presence of E2 is required for the habituation of the
HPA axis to repeated binge-pattern EtOH exposure. In E2 -
treated females, repeated binge-pattern EtOH exposure failed to
significantly increase plasma ACTH and CORT levels, which is
consistent with HPA axis habituation to a repeated stressor.
However, both acute and repeated binge-pattern EtOH exposure
significantly increased circulating ACTH and CORT levels in Ch-
treated controls and no habituation effect was observed. These
data are also consistent with our previous report in which we
showed that there was a habituation effect in gonad intact,
adolescent, female rats following repeated binge-pattern EtOH
exposure [11,19]. Similarly, Lunga et al., [26] showed that OVX
adult female rats had a diminished habituation response to a
repeated restraint stress compared with OVX E2-replaced
animals, further supporting a role for E2 in the female HPA axis
Figure 4. Effects of EtOH treatment on CRH and AVP gene expression in the PVN of ovariectomized female rats replaced with Ch or
E2. CRH (A) and AVP (B) mRNA expression in the PVN of adolescent females replaced either with Ch or E2 and then treatment with either saline, acute,
or binge EtOH. Data are expressed as mRNA copies/mg total RNA. (*) indicates a statistically significant difference from control (p,0.05).
doi:10.1371/journal.pone.0032263.g004
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luciferase activity was measured in IVB cells transfected with a CRH promoter-luciferase construct and treated with 100 mM EtOH for 2.0 h in media
alone or in the presence of 10 nM E2 or 100 nM 3bdiol. Data are expressed as % change in luciferase activity of vehicle treated control. (*) indicates
statistically significant difference compared to vehicle treated control (P,0.05).
doi:10.1371/journal.pone.0032263.g005
Figure 6. Effects of EtOH treatment on AVP gene expression in the SON of ovariectomized female rats. AVP mRNA expression in the
SON of adolescent Ch- or E2 - treated female rats given saline, acute, or repeated binge-pattern EtOH. Data are expressed as mean 6 SEM of AVP
mRNA copies/mg total RNA. (*) indicates a statistically significant difference from control (p,0.05).
doi:10.1371/journal.pone.0032263.g006
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male rats, as a recent study by Bingham et al., [27] demonstrated
that early postnatal activation of androgen receptors is also an
important mediator of the adult habituation response to repeated
stressors.
One of the most striking results in these studies showed that
repeated binge-pattern EtOH exposure, but not acute, signifi-
cantly decreased both AVP and CRH mRNA in OVX Ch-treated
controls. This result was opposite from what we have observed in
gonad intact males [11], where repeated binge-pattern EtOH
exposure significantly increased CRH and AVP gene expression.
It was also contrary to results from females, either intact or E2-
replaced, where EtOH had no effect on CRH and AVP gene
expression in the PVN. [28,29,30]. Taken together, these results
suggest that E2 is required for maintaining the reactive tone of the
HPA axis, possibly by stabilizing steady state CRH and AVP
mRNA levels in females. It also raises the possibility that additional
gonadally-derived factors might be required for mediating the
EtOH-induced increase in CRH and AVP gene expression in
males.
Steady state CRH mRNA is strongly correlated with CRH
promoter activity. Stress-induced increases in circulating gluco-
corticoids inhibit CRH promoter activity, thereby facilitating a
return of the HPA axis towards homeostatic balance [31,32,33].
We predicted that modulation of CRH promoter activity would be
one possible mechanism for the observed E2-mediated mainte-
nance of steady state CRH mRNA following EtOH exposure in
females. Previous studies from our laboratory have shown that
EtOH significantly increased CRH promoter activity after 2 hours
of exposure at concentrations ranging from 12.5 to 100 mM [34].
Importantly for this study, concomitant treatment of EtOH and E2
abolished the effects of EtOH alone on CRH promoter activity (see
Fig. 5), consistent with the observed lack of EtOH effect on CRH
mRNA observed in both gonad-intact and E2-treated female rats.
E2 is derived from the precursor hormone, testosterone (T), via
conversion by the aromatase enzyme. However, T is also readily
converted to 5a-dihydrotestosterone (DHT), which acts exclusively
through androgen receptors, and DHT, can subsequently, be
converted to 3bdiol [35,36,37]. Importantly, 3bdiol is a naturally
occurring selective agonist for estrogen receptor b (ERb) and has
been shown to modulate AVP promoter activity and gene
expression in the PVN [38,39,40,41]. The EtOH-induced increase
in CRH promoter activity was abolished in the presence of E2, but
not 3bdiol, suggesting that the effects of E2 on CRH promoter
activity are not mediated through ERb. Moreover, these results
establish that direct modulation of CRH promoter activity is a
potential mechanism for E2-mediated maintenance of steady state
CRH mRNA in the presence of EtOH.
Repeated binge-pattern EtOH exposure did not change AVP
mRNA expression in the SON of E2 -replaced animals, yet it was
significantly decreased in Ch-treated controls. Previous studies in
our lab and others have shown that EtOH had no effect on AVP
expression in the SON [28], or the magnocellular division of the
PVN, in gonad intact female rats [30], which is consistent with our
results from E2-replaced animals. Notably, however, we observed
a significant decrease in AVP mRNA expression in the SON of
Ch-treated controls. It is well accepted that E2 has neuroprotective
effects after a neuronal insult [42,43,44,45,46,47,48,49], and there
is an increase in aromatase activity, the enzyme required for
conversion of T to E2, after ischemic stroke and other brain
injuries [47,48,49]. Therefore, one possibility is that OVX Ch-
treated females lack E2-mediated neuroprotection and the
population of CRH and AVP containing neurons in the PVN
and SON are decreased as a result. Alternatively, alcohol exposure
has also been shown to reduce AVP mRNA in the SON of rats
bearing PVN lesions [28], suggesting that there is some
cooperation between these two nuclei. In PVN-derived cells,
AVP has been shown to be protective against serum starvation-
induced cell death [50,51]. Therefore, decreased AVP expression
in the PVN, as was observed following repeated binge-pattern
EtOH exposure in our Ch-treated controls, could have potentiated
the reductions in AVP expression we observed in the SON.
Lastly, we showed that E2 -treated females had significantly
lower body weights and gained weight at a slower rate as
compared to Ch-treated females, but EtOH treatment had no
effect on body weight. These findings are consistent with the
known anorexigenic effects of E2, as lack of this hormone in
humans, for example during the menopausal transition, tends to
increase body weight [52]. In addition, body weight data in EtOH
treated groups showed that the repeated binge-pattern alcohol
exposure paradigm employed in our experiments did not inhibit
the normal overall growth of the animals. This result was
consistent with our previous data which showed no differences
in body weight due to EtOH treatment in adolescent animals
[11,34]. In addition this binge EtOH exposure paradigm has been
shown to be reliable for testing the effects of EtOH using an
exposure pattern that is typical for adolescents [18].
Taken together, our data show for the first time that E2 plays a
critical role in mediating the sexually dimorphic effects of repeated
binge-pattern EtOH exposure during adolescence, and that these
sex differences are mediated at the level of CRH promoter
through the interplay of EtOH and estrogen receptor signaling.
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